nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—Parkinson's disease	0.809	1	CbGaD
Tolvaptan—Zafirlukast—CYP2E1—Parkinson's disease	0.00328	0.459	CrCbGaD
Tolvaptan—Zafirlukast—CYP2D6—Parkinson's disease	0.00241	0.337	CrCbGaD
Tolvaptan—Vismodegib—ABCB1—Parkinson's disease	0.00146	0.204	CrCbGaD
Tolvaptan—AVPR1A—GPCR ligand binding—DRD3—Parkinson's disease	0.00056	0.00304	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—DRD3—Parkinson's disease	0.000556	0.00302	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000555	0.00302	CbGpPWpGaD
Tolvaptan—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000552	0.003	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000543	0.00295	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VPS35—Parkinson's disease	0.000541	0.00294	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000539	0.00293	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PENK—Parkinson's disease	0.000539	0.00293	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VPS35—Parkinson's disease	0.000538	0.00292	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PENK—Parkinson's disease	0.000535	0.00291	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000532	0.00289	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000528	0.00287	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—GRM4—Parkinson's disease	0.000516	0.00281	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GRM4—Parkinson's disease	0.000513	0.00279	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR7—Parkinson's disease	0.000506	0.00275	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—DRD2—Parkinson's disease	0.000506	0.00275	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HTR7—Parkinson's disease	0.000502	0.00273	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—DRD2—Parkinson's disease	0.000502	0.00273	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PDYN—Parkinson's disease	0.000493	0.00268	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PENK—Parkinson's disease	0.000489	0.00266	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000489	0.00266	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PENK—Parkinson's disease	0.000486	0.00264	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000477	0.00259	CbGpPWpGaD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—Parkinson's disease	0.000466	0.00253	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000465	0.00253	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000462	0.00251	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—GRM5—Parkinson's disease	0.000458	0.00249	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000455	0.00247	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—DGKQ—Parkinson's disease	0.000449	0.00244	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GPR37—Parkinson's disease	0.000449	0.00244	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PDYN—Parkinson's disease	0.000448	0.00243	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DGKQ—Parkinson's disease	0.000445	0.00242	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GPR37—Parkinson's disease	0.000445	0.00242	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PDYN—Parkinson's disease	0.000444	0.00241	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—GRM5—Parkinson's disease	0.000416	0.00226	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GRM5—Parkinson's disease	0.000413	0.00224	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00041	0.00223	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000407	0.00221	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—EDN1—Parkinson's disease	0.000405	0.0022	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—EDN1—Parkinson's disease	0.000402	0.00219	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000396	0.00215	CbGpPWpGaD
Tolvaptan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000391	0.00213	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00039	0.00212	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000387	0.0021	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00038	0.00206	CbGpPWpGaD
Tolvaptan—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000375	0.00204	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000373	0.00203	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.000371	0.00201	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000362	0.00196	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RIT2—Parkinson's disease	0.000359	0.00195	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RIT2—Parkinson's disease	0.000356	0.00193	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR2A—Parkinson's disease	0.000354	0.00193	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000354	0.00192	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000352	0.00191	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000351	0.00191	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.00035	0.0019	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GRK5—Parkinson's disease	0.00034	0.00185	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000338	0.00184	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GRK5—Parkinson's disease	0.000338	0.00183	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000336	0.00182	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—TAC1—Parkinson's disease	0.000333	0.00181	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000331	0.0018	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000331	0.0018	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00033	0.00179	CbGpPWpGaD
Tolvaptan—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000327	0.00178	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—DRD1—Parkinson's disease	0.000327	0.00177	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000324	0.00176	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000317	0.00172	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—DRD3—Parkinson's disease	0.000316	0.00172	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000314	0.00171	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000313	0.0017	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR1A—Parkinson's disease	0.000307	0.00167	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GRM4—Parkinson's disease	0.000305	0.00166	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000305	0.00166	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000303	0.00165	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GRM4—Parkinson's disease	0.000303	0.00165	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TAC1—Parkinson's disease	0.000302	0.00164	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TAC1—Parkinson's disease	0.0003	0.00163	CbGpPWpGaD
Tolvaptan—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000299	0.00163	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—DRD1—Parkinson's disease	0.000297	0.00161	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000295	0.0016	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—DRD1—Parkinson's disease	0.000294	0.0016	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000293	0.00159	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PENK—Parkinson's disease	0.000289	0.00157	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAG—Parkinson's disease	0.000289	0.00157	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—DRD3—Parkinson's disease	0.000287	0.00156	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PENK—Parkinson's disease	0.000287	0.00156	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAG—Parkinson's disease	0.000287	0.00156	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—DRD2—Parkinson's disease	0.000286	0.00155	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR7—Parkinson's disease	0.000286	0.00155	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—DRD3—Parkinson's disease	0.000285	0.00155	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000284	0.00154	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000284	0.00154	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.000278	0.00151	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000269	0.00146	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000268	0.00146	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000266	0.00145	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PDYN—Parkinson's disease	0.000264	0.00144	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PDYN—Parkinson's disease	0.000263	0.00143	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00026	0.00141	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—DRD2—Parkinson's disease	0.00026	0.00141	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR7—Parkinson's disease	0.00026	0.00141	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—DRD2—Parkinson's disease	0.000258	0.0014	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HTR7—Parkinson's disease	0.000258	0.0014	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GFAP—Parkinson's disease	0.000249	0.00135	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GFAP—Parkinson's disease	0.000247	0.00134	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GRM5—Parkinson's disease	0.000246	0.00134	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000246	0.00134	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GRM5—Parkinson's disease	0.000244	0.00133	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000229	0.00124	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000227	0.00124	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000218	0.00119	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000217	0.00118	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000217	0.00118	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGF20—Parkinson's disease	0.000216	0.00117	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000215	0.00117	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGF20—Parkinson's disease	0.000214	0.00116	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000212	0.00115	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000209	0.00114	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EDN1—Parkinson's disease	0.000208	0.00113	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000208	0.00113	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EDN1—Parkinson's disease	0.000206	0.00112	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000202	0.0011	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.0002	0.00109	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000199	0.00108	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—INSR—Parkinson's disease	0.000193	0.00105	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000192	0.00104	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—INSR—Parkinson's disease	0.000192	0.00104	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGB—Parkinson's disease	0.000182	0.000991	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000182	0.000988	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR1A—Parkinson's disease	0.000181	0.000986	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGB—Parkinson's disease	0.000181	0.000984	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000181	0.000981	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR1A—Parkinson's disease	0.00018	0.000978	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TAC1—Parkinson's disease	0.000179	0.000971	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TAC1—Parkinson's disease	0.000177	0.000964	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—DRD1—Parkinson's disease	0.000175	0.000952	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DRD1—Parkinson's disease	0.000174	0.000945	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—DRD3—Parkinson's disease	0.00017	0.000922	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DRD3—Parkinson's disease	0.000168	0.000915	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000158	0.000861	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000157	0.000855	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000157	0.000853	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.000157	0.000853	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000157	0.000851	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000155	0.00084	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—DRD2—Parkinson's disease	0.000153	0.000834	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR7—Parkinson's disease	0.000153	0.000834	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR7—Parkinson's disease	0.000152	0.000828	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—DRD2—Parkinson's disease	0.000152	0.000828	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000143	0.000776	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000141	0.000765	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000137	0.000746	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000131	0.000709	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000129	0.0007	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF2—Parkinson's disease	0.000129	0.000699	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF2—Parkinson's disease	0.000128	0.000694	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1R—Parkinson's disease	0.000124	0.000675	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1R—Parkinson's disease	0.000123	0.000671	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EDN1—Parkinson's disease	0.000123	0.000667	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EDN1—Parkinson's disease	0.000122	0.000663	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000115	0.000625	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—Parkinson's disease	0.000114	0.000619	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ND3—Parkinson's disease	0.000114	0.000619	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MCCC1—Parkinson's disease	0.000114	0.000619	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NGF—Parkinson's disease	0.000113	0.000613	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NGF—Parkinson's disease	0.000112	0.000609	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000108	0.000588	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000108	0.000585	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR2A—Parkinson's disease	0.000107	0.000584	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000107	0.000584	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TALDO1—Parkinson's disease	0.000107	0.000582	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—OMD—Parkinson's disease	0.000107	0.000582	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000107	0.00058	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR2A—Parkinson's disease	0.000107	0.00058	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000106	0.000577	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000106	0.000575	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NDUFB11—Parkinson's disease	0.000101	0.000551	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOE—Parkinson's disease	9.99e-05	0.000543	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOE—Parkinson's disease	9.92e-05	0.000539	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	9.89e-05	0.000538	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	9.76e-05	0.00053	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCH1—Parkinson's disease	9.68e-05	0.000526	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DBH—Parkinson's disease	8.63e-05	0.000469	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FBP1—Parkinson's disease	8.63e-05	0.000469	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GBA—Parkinson's disease	8.63e-05	0.000469	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—INS—Parkinson's disease	8.53e-05	0.000464	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—INS—Parkinson's disease	8.47e-05	0.00046	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	7.73e-05	0.00042	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.54e-05	0.00041	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.24e-05	0.000393	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	7.1e-05	0.000386	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ND3—Parkinson's disease	7.01e-05	0.000381	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MCCC1—Parkinson's disease	7.01e-05	0.000381	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—OMD—Parkinson's disease	6.59e-05	0.000358	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TALDO1—Parkinson's disease	6.59e-05	0.000358	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—Parkinson's disease	6.35e-05	0.000345	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DDC—Parkinson's disease	6.33e-05	0.000344	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—Parkinson's disease	6.31e-05	0.000343	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—Parkinson's disease	6.31e-05	0.000343	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.29e-05	0.000342	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—Parkinson's disease	6.27e-05	0.000341	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	6.25e-05	0.00034	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA4—Parkinson's disease	5.98e-05	0.000325	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCH1—Parkinson's disease	5.96e-05	0.000324	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK8—Parkinson's disease	5.84e-05	0.000317	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK8—Parkinson's disease	5.8e-05	0.000315	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	5.62e-05	0.000305	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLA2G6—Parkinson's disease	5.38e-05	0.000293	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MAOB—Parkinson's disease	5.33e-05	0.00029	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DBH—Parkinson's disease	5.32e-05	0.000289	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FBP1—Parkinson's disease	5.32e-05	0.000289	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GBA—Parkinson's disease	5.32e-05	0.000289	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2D6—Parkinson's disease	3.96e-05	0.000215	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DDC—Parkinson's disease	3.9e-05	0.000212	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CTGF—Parkinson's disease	3.89e-05	0.000211	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—Parkinson's disease	3.73e-05	0.000203	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—Parkinson's disease	3.7e-05	0.000201	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA4—Parkinson's disease	3.68e-05	0.0002	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2E1—Parkinson's disease	3.62e-05	0.000197	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NQO1—Parkinson's disease	3.58e-05	0.000195	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TH—Parkinson's disease	3.53e-05	0.000192	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYCS—Parkinson's disease	3.39e-05	0.000184	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	3.32e-05	0.00018	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MAOB—Parkinson's disease	3.28e-05	0.000178	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—COMT—Parkinson's disease	3e-05	0.000163	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.99e-05	0.000162	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MAOA—Parkinson's disease	2.98e-05	0.000162	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.95e-05	0.00016	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.75e-05	0.000149	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPX1—Parkinson's disease	2.63e-05	0.000143	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.44e-05	0.000133	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.43e-05	0.000132	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.4e-05	0.00013	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOE—Parkinson's disease	2.26e-05	0.000123	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.23e-05	0.000121	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.21e-05	0.00012	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TH—Parkinson's disease	2.18e-05	0.000118	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.09e-05	0.000113	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—INS—Parkinson's disease	1.93e-05	0.000105	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—COMT—Parkinson's disease	1.85e-05	0.000101	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.84e-05	0.0001	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.84e-05	9.98e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.82e-05	9.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.74e-05	9.47e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.69e-05	9.19e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.62e-05	8.8e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.5e-05	8.12e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOE—Parkinson's disease	1.39e-05	7.56e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—INS—Parkinson's disease	1.19e-05	6.46e-05	CbGpPWpGaD
